{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:57:14Z","timestamp":1793721434288,"version":"4.6.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["UM1DA049417"],"award-info":[{"award-number":["UM1DA049417"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["NCT04111939"],"award-info":[{"award-number":["NCT04111939"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.japh.2026.103044","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:53:16Z","timestamp":1770828796000},"page":"103044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Collaboration with community partners to expand naloxone access in the HEALing Communities Study"],"prefix":"10.1016","volume":"66","author":[{"given":"Tim","family":"Ingram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Rubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sierra","family":"Dantzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3977-8250","authenticated-orcid":false,"given":"Jolene","family":"DeFiore-Hyrmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6683-0053","authenticated-orcid":false,"given":"Jennifer L.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4057-2583","authenticated-orcid":false,"given":"Joel","family":"Sprunger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3364-0739","authenticated-orcid":false,"given":"T. John","family":"Winhusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2026.103044_bib1","series-title":"Drug overdose deaths in the United States, 2002\u20132022. NCHS Data Brief, no 491","author":"Spencer","year":"2024"},{"issue":"2","key":"10.1016\/j.japh.2026.103044_bib3","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1097\/ADM.0000000000000874","article-title":"During the COVID-19 pandemic, opioid overdose deaths revert to previous record levels in Ohio","volume":"16","author":"Vieson","year":"2022","journal-title":"J Addict Med"},{"key":"10.1016\/j.japh.2026.103044_bib4","series-title":"2022 Ohio Unintentional Drug Overdose Report","year":"2023"},{"issue":"1","key":"10.1016\/j.japh.2026.103044_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-7517-5-2","article-title":"A qualitative study of overdose responses among Chicago IDUs","volume":"5","author":"Sherman","year":"2008","journal-title":"Harm Reduction J"},{"key":"10.1016\/j.japh.2026.103044_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.japh.2026.103044_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-158-1-201301010-00003","article-title":"Cost-Effectiveness of distributing naloxone to heroin users for lay overdose reversal","volume":"158","author":"Coffin","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.japh.2026.103044_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.trsl.2021.03.001","article-title":"Naloxone's role in the national opioid crisis-past struggles, current efforts, and future opportunities","volume":"234","author":"Bennett","year":"2021","journal-title":"Transl Res"},{"key":"10.1016\/j.japh.2026.103044_bib9","article-title":"Overdose education and naloxone distribution program design informed by people who use drugs and naloxone distributors","volume":"35","author":"Enich","year":"2023","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.japh.2026.103044_bib10","doi-asserted-by":"crossref","first-page":"100126","DOI":"10.1016\/j.dadr.2022.100126","article-title":"The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses","volume":"6","author":"Bohler","year":"2023","journal-title":"Drug alcohol Depend Rep"},{"issue":"4","key":"10.1016\/j.japh.2026.103044_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ADM.0000000000000310","article-title":"Vermont hub-and-spoke model of care for opioid use disorder: development, implementation, and impact","volume":"11","author":"Brooklyn","year":"2017","journal-title":"J Addict Med"},{"key":"10.1016\/j.japh.2026.103044_bib17","article-title":"Effects of the Communities that Heal (CTH) intervention on perceived opioid-related community stigma in the HEALing Communities Study: results of a multi-site, community-level, cluster-randomized trial","volume":"32","author":"Davis","year":"2024","journal-title":"Lancet Reg Health Am"},{"issue":"11","key":"10.1016\/j.japh.2026.103044_bib18","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2401177","article-title":"Community-Based cluster-randomized trial to reduce opioid overdose deaths","volume":"391","year":"2024","journal-title":"New Engl J Med"},{"key":"10.1016\/j.japh.2026.103044_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108329","article-title":"Addressing opioid overdose deaths: the vision for the HEALing Communities study","volume":"217","author":"Chandler","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2026.103044_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108327","article-title":"Introduction to the special issue on the HEALing Communities Study","volume":"217","author":"El-Bassel","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2026.103044_bib21","article-title":"The HEALing (helping to end Addiction long-term (SM)) Communities Study: protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices","volume":"217","author":"Consortium","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2026.103044_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108326","article-title":"Community engagement to implement evidence-based practices in the HEALing Communities Study","volume":"217","author":"Sprague Martinez","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2026.103044_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108325","article-title":"The Opioid-Overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study","volume":"217","author":"Winhusen","year":"2020","journal-title":"Drug Alcohol Depend"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319126000294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319126000294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T19:37:58Z","timestamp":1780947478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319126000294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1544319126000294"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2026.103044","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Collaboration with community partners to expand naloxone access in the HEALing Communities Study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2026.103044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"103044"}}